FormFore's profile picture. We produce the most accurate insider trading data in the industry.
Previously Form Fore.

Sherlock Data | Insider Trading Analytics

@FormFore

We produce the most accurate insider trading data in the industry. Previously Form Fore.

ปักหมุด

🚨 BREAKING: ~$256K CEO BUY 🚨  Jay Luly, the CEO of $ENTA, reported a $256K stock purchase, increasing his stake by 5.61%. Luly is the largest insider shareholder at $ENTA, which reported a 22% earnings beat on February 10th. Largest buy in 3+ yrs.

FormFore's tweet image. 🚨 BREAKING: ~$256K CEO BUY 🚨

 Jay Luly, the CEO of $ENTA, reported a $256K stock purchase, increasing his stake by 5.61%.

Luly is the largest insider shareholder at $ENTA, which reported a 22% earnings beat on February 10th.

Largest buy in 3+ yrs.
FormFore's tweet image. 🚨 BREAKING: ~$256K CEO BUY 🚨

 Jay Luly, the CEO of $ENTA, reported a $256K stock purchase, increasing his stake by 5.61%.

Luly is the largest insider shareholder at $ENTA, which reported a 22% earnings beat on February 10th.

Largest buy in 3+ yrs.
FormFore's tweet image. 🚨 BREAKING: ~$256K CEO BUY 🚨

 Jay Luly, the CEO of $ENTA, reported a $256K stock purchase, increasing his stake by 5.61%.

Luly is the largest insider shareholder at $ENTA, which reported a 22% earnings beat on February 10th.

Largest buy in 3+ yrs.

🚨 BREAKING: 7-FIGURE CFO BUY 🚨 Paul Kim, the CFO and Treasurer of $FLGT, has reported a nearly $1.6 million buy, increasing his ownership stake by 70.29%. It’s the largest insider buy at Fulgent Genetics in 3+ years.

FormFore's tweet image. 🚨 BREAKING: 7-FIGURE CFO BUY 🚨

Paul Kim, the CFO and Treasurer of $FLGT, has reported a nearly $1.6 million buy, increasing his ownership stake by 70.29%.

It’s the largest insider buy at Fulgent Genetics in 3+ years.
FormFore's tweet image. 🚨 BREAKING: 7-FIGURE CFO BUY 🚨

Paul Kim, the CFO and Treasurer of $FLGT, has reported a nearly $1.6 million buy, increasing his ownership stake by 70.29%.

It’s the largest insider buy at Fulgent Genetics in 3+ years.
FormFore's tweet image. 🚨 BREAKING: 7-FIGURE CFO BUY 🚨

Paul Kim, the CFO and Treasurer of $FLGT, has reported a nearly $1.6 million buy, increasing his ownership stake by 70.29%.

It’s the largest insider buy at Fulgent Genetics in 3+ years.

Anecdotally, seeing a lot of insider buys come in today. Feel like the past few weeks have been rather spotty; not a ton of action. Multiple alerts firing the past few hrs.


🚨 BREAKING: 7-FIGURE CEO BUY 🚨  Erik Frywald, the CEO of $IFF, has reported a ~$2 million buy, increasing his stake by ~160%. EF is the largest insider shareholder. $IFF reported a ~20% earnings beat on 2/18. Largest insider buy in at least 3 years.

FormFore's tweet image. 🚨 BREAKING: 7-FIGURE CEO BUY 🚨

 Erik Frywald, the CEO of $IFF, has reported a ~$2 million buy, increasing his stake by ~160%.

EF is the largest insider shareholder.

$IFF reported a ~20% earnings beat on 2/18.

Largest insider buy in at least 3 years.
FormFore's tweet image. 🚨 BREAKING: 7-FIGURE CEO BUY 🚨

 Erik Frywald, the CEO of $IFF, has reported a ~$2 million buy, increasing his stake by ~160%.

EF is the largest insider shareholder.

$IFF reported a ~20% earnings beat on 2/18.

Largest insider buy in at least 3 years.
FormFore's tweet image. 🚨 BREAKING: 7-FIGURE CEO BUY 🚨

 Erik Frywald, the CEO of $IFF, has reported a ~$2 million buy, increasing his stake by ~160%.

EF is the largest insider shareholder.

$IFF reported a ~20% earnings beat on 2/18.

Largest insider buy in at least 3 years.

🚨 BREAKING: 8-FIGURE INSIDER BUY 🚨 Coliseum Capital, a 10% Owner of $OMI, has reported a ~$27.4 million buy, increasing their stake by 37.43%. CC is the largest insider shareholder at $OMI, and it is the largest insider buy at Ownes & Minor in ~3 years.

FormFore's tweet image. 🚨 BREAKING: 8-FIGURE INSIDER BUY 🚨

Coliseum Capital, a 10% Owner of $OMI, has reported a ~$27.4 million buy, increasing their stake by 37.43%.

CC is the largest insider shareholder at $OMI, and it is the largest insider buy at Ownes & Minor in ~3 years.
FormFore's tweet image. 🚨 BREAKING: 8-FIGURE INSIDER BUY 🚨

Coliseum Capital, a 10% Owner of $OMI, has reported a ~$27.4 million buy, increasing their stake by 37.43%.

CC is the largest insider shareholder at $OMI, and it is the largest insider buy at Ownes & Minor in ~3 years.
FormFore's tweet image. 🚨 BREAKING: 8-FIGURE INSIDER BUY 🚨

Coliseum Capital, a 10% Owner of $OMI, has reported a ~$27.4 million buy, increasing their stake by 37.43%.

CC is the largest insider shareholder at $OMI, and it is the largest insider buy at Ownes & Minor in ~3 years.

🚨 BREAKING: 7-FIGURE CEO BUY 🚨 Stephane Bancel, the CEO of $MRNA, has reported a ~$5 million buy, raising his stake by ~0.76%. Another insider bought ~$1M (6.84%). Despite the small ownership bumps, this is the most insider buying at Moderna in over a year.

FormFore's tweet image. 🚨 BREAKING: 7-FIGURE CEO BUY 🚨

Stephane Bancel, the CEO of $MRNA, has reported a ~$5 million buy, raising his stake by ~0.76%.

Another insider bought ~$1M (6.84%).

Despite the small ownership bumps, this is the most insider buying at Moderna in over a year.
FormFore's tweet image. 🚨 BREAKING: 7-FIGURE CEO BUY 🚨

Stephane Bancel, the CEO of $MRNA, has reported a ~$5 million buy, raising his stake by ~0.76%.

Another insider bought ~$1M (6.84%).

Despite the small ownership bumps, this is the most insider buying at Moderna in over a year.
FormFore's tweet image. 🚨 BREAKING: 7-FIGURE CEO BUY 🚨

Stephane Bancel, the CEO of $MRNA, has reported a ~$5 million buy, raising his stake by ~0.76%.

Another insider bought ~$1M (6.84%).

Despite the small ownership bumps, this is the most insider buying at Moderna in over a year.

🚨 BREAKING: ~$2 MILLION BUY 🚨 Matthew Wilks, the Executive Chairman of $ACDC, has reported a ~$2 million buy, increasing his stake by 19.03%. There was ~$60+ million in insider buying at $ACDC in Q2 and Q3 ‘24.

FormFore's tweet image. 🚨 BREAKING: ~$2 MILLION BUY 🚨

Matthew Wilks, the Executive Chairman of $ACDC, has reported a ~$2 million buy, increasing his stake by 19.03%.

There was ~$60+ million in insider buying at $ACDC in Q2 and Q3 ‘24.
FormFore's tweet image. 🚨 BREAKING: ~$2 MILLION BUY 🚨

Matthew Wilks, the Executive Chairman of $ACDC, has reported a ~$2 million buy, increasing his stake by 19.03%.

There was ~$60+ million in insider buying at $ACDC in Q2 and Q3 ‘24.
FormFore's tweet image. 🚨 BREAKING: ~$2 MILLION BUY 🚨

Matthew Wilks, the Executive Chairman of $ACDC, has reported a ~$2 million buy, increasing his stake by 19.03%.

There was ~$60+ million in insider buying at $ACDC in Q2 and Q3 ‘24.
FormFore's tweet image. 🚨 BREAKING: ~$2 MILLION BUY 🚨

Matthew Wilks, the Executive Chairman of $ACDC, has reported a ~$2 million buy, increasing his stake by 19.03%.

There was ~$60+ million in insider buying at $ACDC in Q2 and Q3 ‘24.

🚨 BREAKING: NEW CFO BUY 🚨 Patrick Brennan, the CFO of $SIGI, has reported a ~$250K purchase, increasing his ownership stake by 24.83%. A separate insider bought ~$120K a few days prior for a 6.62% stake increase.

FormFore's tweet image. 🚨 BREAKING: NEW CFO BUY 🚨

Patrick Brennan, the CFO of $SIGI, has reported a ~$250K purchase, increasing his ownership stake by 24.83%.

A separate insider bought ~$120K a few days prior for a 6.62% stake increase.
FormFore's tweet image. 🚨 BREAKING: NEW CFO BUY 🚨

Patrick Brennan, the CFO of $SIGI, has reported a ~$250K purchase, increasing his ownership stake by 24.83%.

A separate insider bought ~$120K a few days prior for a 6.62% stake increase.
FormFore's tweet image. 🚨 BREAKING: NEW CFO BUY 🚨

Patrick Brennan, the CFO of $SIGI, has reported a ~$250K purchase, increasing his ownership stake by 24.83%.

A separate insider bought ~$120K a few days prior for a 6.62% stake increase.

🚨 BREAKING: NEW INSIDER BUY 🚨  Alan Mateo, a Director at $TXG, has reported a $445K purchase, increasing his stake by 184.41%. It’s the first insider buy at $TXG since May ‘22.

FormFore's tweet image. 🚨 BREAKING: NEW INSIDER BUY 🚨

 Alan Mateo, a Director at $TXG, has reported a $445K purchase, increasing his stake by 184.41%.

It’s the first insider buy at $TXG since May ‘22.
FormFore's tweet image. 🚨 BREAKING: NEW INSIDER BUY 🚨

 Alan Mateo, a Director at $TXG, has reported a $445K purchase, increasing his stake by 184.41%.

It’s the first insider buy at $TXG since May ‘22.
FormFore's tweet image. 🚨 BREAKING: NEW INSIDER BUY 🚨

 Alan Mateo, a Director at $TXG, has reported a $445K purchase, increasing his stake by 184.41%.

It’s the first insider buy at $TXG since May ‘22.
FormFore's tweet image. 🚨 BREAKING: NEW INSIDER BUY 🚨

 Alan Mateo, a Director at $TXG, has reported a $445K purchase, increasing his stake by 184.41%.

It’s the first insider buy at $TXG since May ‘22.

🚨 BREAKING: CFO INSIDER BUY 🚨  Taryn Miller, the CFO of $WWW, has reported a ~$100K buy, increasing her ownership stake by 158.2%. The same day, a separate insider bought ~$535K in stock. These are the first insider buys at $WWW in ~2 years.

FormFore's tweet image. 🚨 BREAKING: CFO INSIDER BUY 🚨

 Taryn Miller, the CFO of $WWW, has reported a ~$100K buy, increasing her ownership stake by 158.2%.

The same day, a separate insider bought ~$535K  in stock.

These are the first insider buys at $WWW in ~2 years.
FormFore's tweet image. 🚨 BREAKING: CFO INSIDER BUY 🚨

 Taryn Miller, the CFO of $WWW, has reported a ~$100K buy, increasing her ownership stake by 158.2%.

The same day, a separate insider bought ~$535K  in stock.

These are the first insider buys at $WWW in ~2 years.
FormFore's tweet image. 🚨 BREAKING: CFO INSIDER BUY 🚨

 Taryn Miller, the CFO of $WWW, has reported a ~$100K buy, increasing her ownership stake by 158.2%.

The same day, a separate insider bought ~$535K  in stock.

These are the first insider buys at $WWW in ~2 years.
FormFore's tweet image. 🚨 BREAKING: CFO INSIDER BUY 🚨

 Taryn Miller, the CFO of $WWW, has reported a ~$100K buy, increasing her ownership stake by 158.2%.

The same day, a separate insider bought ~$535K  in stock.

These are the first insider buys at $WWW in ~2 years.

🚨 BREAKING: ~$600K IN BUYS 🚨 Edward West, the CEO of $MITK, has reported a ~$506K buy, increasing his stake by 29.34%. Another insider also bought ~$98K for a 17.90% increase. $MITK had a small earnings beat that was reported on Feb 10th.

FormFore's tweet image. 🚨 BREAKING: ~$600K IN BUYS 🚨

Edward West, the CEO of $MITK, has reported a ~$506K buy, increasing his stake by 29.34%.

Another insider also bought ~$98K for a 17.90% increase.

$MITK had a small earnings beat that was reported on Feb 10th.
FormFore's tweet image. 🚨 BREAKING: ~$600K IN BUYS 🚨

Edward West, the CEO of $MITK, has reported a ~$506K buy, increasing his stake by 29.34%.

Another insider also bought ~$98K for a 17.90% increase.

$MITK had a small earnings beat that was reported on Feb 10th.
FormFore's tweet image. 🚨 BREAKING: ~$600K IN BUYS 🚨

Edward West, the CEO of $MITK, has reported a ~$506K buy, increasing his stake by 29.34%.

Another insider also bought ~$98K for a 17.90% increase.

$MITK had a small earnings beat that was reported on Feb 10th.
FormFore's tweet image. 🚨 BREAKING: ~$600K IN BUYS 🚨

Edward West, the CEO of $MITK, has reported a ~$506K buy, increasing his stake by 29.34%.

Another insider also bought ~$98K for a 17.90% increase.

$MITK had a small earnings beat that was reported on Feb 10th.

🚨 BREAKING: 8-FIGURE INSIDER BUY 🚨 Apeiro Investment Group, a 10% Owner of $ATAI, has reported a ~$22.8 MILLION buy, increasing their stake by 34.38%. The shares were likely purchased as part of the public offering announced by $ATAI on February 12th.

FormFore's tweet image. 🚨 BREAKING: 8-FIGURE INSIDER BUY 🚨

Apeiro Investment Group, a 10% Owner of $ATAI, has reported a ~$22.8 MILLION buy, increasing their stake by 34.38%.

The shares were likely purchased as part of the public offering announced by $ATAI on February 12th.
FormFore's tweet image. 🚨 BREAKING: 8-FIGURE INSIDER BUY 🚨

Apeiro Investment Group, a 10% Owner of $ATAI, has reported a ~$22.8 MILLION buy, increasing their stake by 34.38%.

The shares were likely purchased as part of the public offering announced by $ATAI on February 12th.
FormFore's tweet image. 🚨 BREAKING: 8-FIGURE INSIDER BUY 🚨

Apeiro Investment Group, a 10% Owner of $ATAI, has reported a ~$22.8 MILLION buy, increasing their stake by 34.38%.

The shares were likely purchased as part of the public offering announced by $ATAI on February 12th.

🚨 JUST IN: Another ~$2.2 million in insider buys was reported by Orbmided Advisors, a 10% Owner at $MBX, increasing their stake by a few percentage points. They are the biotech's largest insider shareholder.

FormFore's tweet image. 🚨 JUST IN: Another ~$2.2 million in insider buys was reported by Orbmided Advisors, a 10% Owner at $MBX, increasing their stake by a few percentage points.

They are the biotech's largest insider shareholder.
FormFore's tweet image. 🚨 JUST IN: Another ~$2.2 million in insider buys was reported by Orbmided Advisors, a 10% Owner at $MBX, increasing their stake by a few percentage points.

They are the biotech's largest insider shareholder.
FormFore's tweet image. 🚨 JUST IN: Another ~$2.2 million in insider buys was reported by Orbmided Advisors, a 10% Owner at $MBX, increasing their stake by a few percentage points.

They are the biotech's largest insider shareholder.

🚨 BREAKING: ~$535K INSIDER PURCHASE 🚨 Kent Hawryluk, the CEO of $MBX, just reported the purchase of ~$535K in stock, increasing his stake by 5.68%. $MBX is estimated to report earnings on Feb 21st (pre-market), per Robinhood.

FormFore's tweet image. 🚨 BREAKING: ~$535K INSIDER PURCHASE 🚨

Kent Hawryluk, the CEO of $MBX, just reported the purchase of ~$535K in stock, increasing his stake by 5.68%.

$MBX is estimated to report earnings on Feb 21st (pre-market), per Robinhood.
FormFore's tweet image. 🚨 BREAKING: ~$535K INSIDER PURCHASE 🚨

Kent Hawryluk, the CEO of $MBX, just reported the purchase of ~$535K in stock, increasing his stake by 5.68%.

$MBX is estimated to report earnings on Feb 21st (pre-market), per Robinhood.
FormFore's tweet image. 🚨 BREAKING: ~$535K INSIDER PURCHASE 🚨

Kent Hawryluk, the CEO of $MBX, just reported the purchase of ~$535K in stock, increasing his stake by 5.68%.

$MBX is estimated to report earnings on Feb 21st (pre-market), per Robinhood.


🚨 BREAKING: $2M INSIDER BUY 🚨 Michael Mahoney, a Director at $CVS, has reported a ~$2 million purchase, increasing his stake by 190.27%. $CVS reported a ~30% earnings beat on February 12th. It’s the largest insider buy at the company in 3+ years.

FormFore's tweet image. 🚨 BREAKING: $2M INSIDER BUY 🚨

Michael Mahoney, a Director at $CVS, has reported a ~$2 million purchase, increasing his stake by 190.27%.

$CVS reported a ~30% earnings beat on February 12th.

It’s the largest insider buy at the company in 3+ years.
FormFore's tweet image. 🚨 BREAKING: $2M INSIDER BUY 🚨

Michael Mahoney, a Director at $CVS, has reported a ~$2 million purchase, increasing his stake by 190.27%.

$CVS reported a ~30% earnings beat on February 12th.

It’s the largest insider buy at the company in 3+ years.
FormFore's tweet image. 🚨 BREAKING: $2M INSIDER BUY 🚨

Michael Mahoney, a Director at $CVS, has reported a ~$2 million purchase, increasing his stake by 190.27%.

$CVS reported a ~30% earnings beat on February 12th.

It’s the largest insider buy at the company in 3+ years.

🚨$2 MILLION INSIDER BUY 🚨 Philip Satre, a Director at $WYNN, has reported a ~$2 million buy, increasing his stake by 66.7%. The company reported an ~81% earnings beat on February 13th. Satre bought shares 2 trading days later. Largest insider buy at $WYNN in 3+ yrs.

FormFore's tweet image. 🚨$2 MILLION INSIDER BUY 🚨

Philip Satre, a Director at $WYNN, has reported a ~$2 million buy, increasing his stake by 66.7%.

The company reported an ~81% earnings beat on February 13th. Satre bought shares 2 trading days later.

Largest insider buy at $WYNN in 3+ yrs.
FormFore's tweet image. 🚨$2 MILLION INSIDER BUY 🚨

Philip Satre, a Director at $WYNN, has reported a ~$2 million buy, increasing his stake by 66.7%.

The company reported an ~81% earnings beat on February 13th. Satre bought shares 2 trading days later.

Largest insider buy at $WYNN in 3+ yrs.
FormFore's tweet image. 🚨$2 MILLION INSIDER BUY 🚨

Philip Satre, a Director at $WYNN, has reported a ~$2 million buy, increasing his stake by 66.7%.

The company reported an ~81% earnings beat on February 13th. Satre bought shares 2 trading days later.

Largest insider buy at $WYNN in 3+ yrs.
FormFore's tweet image. 🚨$2 MILLION INSIDER BUY 🚨

Philip Satre, a Director at $WYNN, has reported a ~$2 million buy, increasing his stake by 66.7%.

The company reported an ~81% earnings beat on February 13th. Satre bought shares 2 trading days later.

Largest insider buy at $WYNN in 3+ yrs.

🚨 BREAKING: NEW INSIDER BUY 🚨 Robert Moran, a director at $HBI, has reported a ~$450K purchase, increasing his stake by 52.89%. The buys are in spite of a recent ~20% price decline as CEO Steve Bratspies announced his departure and $HBI missed analyst revenue targets.

FormFore's tweet image. 🚨 BREAKING: NEW INSIDER BUY 🚨

Robert Moran, a director at $HBI, has reported a ~$450K purchase, increasing his stake by 52.89%.

The buys are in spite of a recent ~20% price decline as CEO Steve Bratspies announced his departure and $HBI missed analyst revenue targets.
FormFore's tweet image. 🚨 BREAKING: NEW INSIDER BUY 🚨

Robert Moran, a director at $HBI, has reported a ~$450K purchase, increasing his stake by 52.89%.

The buys are in spite of a recent ~20% price decline as CEO Steve Bratspies announced his departure and $HBI missed analyst revenue targets.
FormFore's tweet image. 🚨 BREAKING: NEW INSIDER BUY 🚨

Robert Moran, a director at $HBI, has reported a ~$450K purchase, increasing his stake by 52.89%.

The buys are in spite of a recent ~20% price decline as CEO Steve Bratspies announced his departure and $HBI missed analyst revenue targets.

Nearly 2 months ago, we flagged ~$5.2 million in insider buys at $PGNY from their CEO and Executive Chairman. The stock is up ~56% since then. That’s ~$2.9 million in unrealized profits. At the literal BOTTOM for the stock.

FormFore's tweet image. Nearly 2 months ago, we flagged ~$5.2 million in insider buys at $PGNY from their CEO and Executive Chairman.

The stock is up ~56% since then. That’s ~$2.9 million in unrealized profits.

At the literal BOTTOM for the stock.
FormFore's tweet image. Nearly 2 months ago, we flagged ~$5.2 million in insider buys at $PGNY from their CEO and Executive Chairman.

The stock is up ~56% since then. That’s ~$2.9 million in unrealized profits.

At the literal BOTTOM for the stock.

🚨7-FIGURE BUYS FROM CEO & CHAIRMAN🚨 Two execs at $PGNY bought ~$5.2 million in shares: - David Schlanger (Chairman), stake up by 191.65% - Peter Anevski (CEO), stake up by 90.32% These are the largest buys at PGNY in at least 3 years. Progyny is at 2-year price lows.

FormFore's tweet image. 🚨7-FIGURE BUYS FROM CEO & CHAIRMAN🚨

Two execs at $PGNY bought ~$5.2 million in shares:
- David Schlanger (Chairman), stake up by 191.65%
- Peter Anevski (CEO), stake up by 90.32%

These are the largest buys at PGNY in at least 3 years.

Progyny is at 2-year price lows.
FormFore's tweet image. 🚨7-FIGURE BUYS FROM CEO & CHAIRMAN🚨

Two execs at $PGNY bought ~$5.2 million in shares:
- David Schlanger (Chairman), stake up by 191.65%
- Peter Anevski (CEO), stake up by 90.32%

These are the largest buys at PGNY in at least 3 years.

Progyny is at 2-year price lows.
FormFore's tweet image. 🚨7-FIGURE BUYS FROM CEO & CHAIRMAN🚨

Two execs at $PGNY bought ~$5.2 million in shares:
- David Schlanger (Chairman), stake up by 191.65%
- Peter Anevski (CEO), stake up by 90.32%

These are the largest buys at PGNY in at least 3 years.

Progyny is at 2-year price lows.
FormFore's tweet image. 🚨7-FIGURE BUYS FROM CEO & CHAIRMAN🚨

Two execs at $PGNY bought ~$5.2 million in shares:
- David Schlanger (Chairman), stake up by 191.65%
- Peter Anevski (CEO), stake up by 90.32%

These are the largest buys at PGNY in at least 3 years.

Progyny is at 2-year price lows.


🚨$2M INSIDER BUY🚨  Steven Demetriou, the Exec Chair of $AMTM, reported a ~$2 million stock purchase, raising his stake by 18.37%. He also bought ~521K shares via txn code “J” - not specified - for a total ownership increase of ~2,636%. $AMTM had a modest earnings beat of…

FormFore's tweet image. 🚨$2M INSIDER BUY🚨

 Steven Demetriou, the Exec Chair of $AMTM, reported a ~$2 million stock purchase, raising his stake by 18.37%.

He also bought ~521K shares via txn code “J” - not specified - for a total ownership increase of ~2,636%.

$AMTM had a modest earnings beat of…
FormFore's tweet image. 🚨$2M INSIDER BUY🚨

 Steven Demetriou, the Exec Chair of $AMTM, reported a ~$2 million stock purchase, raising his stake by 18.37%.

He also bought ~521K shares via txn code “J” - not specified - for a total ownership increase of ~2,636%.

$AMTM had a modest earnings beat of…
FormFore's tweet image. 🚨$2M INSIDER BUY🚨

 Steven Demetriou, the Exec Chair of $AMTM, reported a ~$2 million stock purchase, raising his stake by 18.37%.

He also bought ~521K shares via txn code “J” - not specified - for a total ownership increase of ~2,636%.

$AMTM had a modest earnings beat of…

🚨 BREAKING: Pharma Insider Buy 🚨 Ronald Blaylock, a Director at $PFE, has reported a ~$499K purchase, increasing his ownership stake by 149.67%. It’s the first buy at Pfizer since October, and the largest since at least May ‘22.

FormFore's tweet image. 🚨 BREAKING: Pharma Insider Buy 🚨

Ronald Blaylock, a Director at $PFE, has reported a ~$499K purchase, increasing his ownership stake by 149.67%.

It’s the first buy at Pfizer since October, and the largest since at least May ‘22.
FormFore's tweet image. 🚨 BREAKING: Pharma Insider Buy 🚨

Ronald Blaylock, a Director at $PFE, has reported a ~$499K purchase, increasing his ownership stake by 149.67%.

It’s the first buy at Pfizer since October, and the largest since at least May ‘22.
FormFore's tweet image. 🚨 BREAKING: Pharma Insider Buy 🚨

Ronald Blaylock, a Director at $PFE, has reported a ~$499K purchase, increasing his ownership stake by 149.67%.

It’s the first buy at Pfizer since October, and the largest since at least May ‘22.
FormFore's tweet image. 🚨 BREAKING: Pharma Insider Buy 🚨

Ronald Blaylock, a Director at $PFE, has reported a ~$499K purchase, increasing his ownership stake by 149.67%.

It’s the first buy at Pfizer since October, and the largest since at least May ‘22.

Loading...

Something went wrong.


Something went wrong.